scispace - formally typeset
R

Richard D. Schulick

Researcher at Anschutz Medical Campus

Publications -  430
Citations -  46812

Richard D. Schulick is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 98, co-authored 398 publications receiving 39358 citations. Previous affiliations of Richard D. Schulick include Johns Hopkins University School of Medicine & American College of Surgeons.

Papers
More filters
Journal ArticleDOI

The Clavien-Dindo classification of surgical complications: five-year experience.

TL;DR: This 5-year evaluation provides strong evidence that the classification of complications is valid and applicable worldwide in many fields of surgery, and subjective, inaccurate, or confusing terms such as “minor or major” should be removed from the surgical literature.
Journal ArticleDOI

The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula : 11 Years After

TL;DR: This new definition and grading system of postoperative pancreatic Fistula should lead to a more universally consistent evaluation of operative outcomes after pancreatic operation and will allow for a better comparison of techniques used to mitigate the rate and clinical impact of a pancreatic fistula.
Journal ArticleDOI

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Andrew V. Biankin, +140 more
- 15 Nov 2012 - 
TL;DR: It is found that frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, are also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement ofAxon guidance genes in pancreatic carcinogenesis.
Journal ArticleDOI

Trends in long-term survival following liver resection for hepatic colorectal metastases.

TL;DR: Long-term survival following liver resection for colorectal metastases has improved significantly in recent years at this institution, and contributing factors may include the use of newer preoperative and intraoperative imaging, increased use of chemotherapy, and salvage surgical therapy.